Treatment Options for Hepatitis A and E: A Non-Systematic Review

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are common causes of liver disease.
• Transmission is primarily fecal-oral, leading to outbreaks in areas with poor sanitation.
• Both viruses induce liver injury through immune responses, with self-limiting acute illness in most cases.

Purpose of the Study:

• To provide a comprehensive review of the current understanding of Hepatitis A and E.
• To summarize clinical manifestations, including severe and chronic outcomes.
• To evaluate existing and emerging therapeutic strategies and vaccines.

Main Methods:

• Non-systematic literature review.
• Analysis of clinical manifestations and immune responses.
• Assessment of treatment efficacy and vaccine development.

Main Results:

• HAV and HEV infections typically present as acute, self-limiting liver disease.
• Vulnerable populations may experience severe acute disease or chronic manifestations.
• Treatment options are limited, primarily supportive, though some agents show promise in vitro and clinical trials.
• An HAV vaccine is available; HEV vaccines are in development with promising results.

Conclusions:

• Hepatitis A and E share common transmission routes and immune-driven liver injury patterns.
• While acute infections are usually mild, severe and chronic forms necessitate further research into effective treatments.
• Vaccination remains a key strategy, with an established HAV vaccine and developing HEV vaccines.